Xinjun Liang

机构：Hubei Cancer Hospital · ORCID：0000-0002-5221-6589

发表论文 20 篇 · 总被引 498 次 · h-index 8

代表论文

• Expression profile of mammalian microRNAs in endometrioid adenocarcinoma (2008 · European Journal of Cancer Prevention · 被引 169)
• β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8 + T cells through regulation of IL-10 (2015 · Proceedings of the National Academy of Sciences · 被引 109)
• β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells (2013 · Journal of Leukocyte Biology · 被引 70)
• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 41)
• Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury (2011 · Neuroscience Letters · 被引 24)
• The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial (2025 · Nature Medicine · 被引 22)